Infectious Disease Calculators
27 calculators
- Sequential Organ Failure Assessment (SOFA) — Sepsis-3Quick SOFA (qSOFA) for rapid sepsis identification outside ICU. Score ≥2 warrants full assessment.
- PORT Score / PSI for PneumoniaPneumonia Severity Index (PSI) for stratifying CAP mortality risk. Patients in classes I–II can be treated as outpatients.
- HIV Risk Assessment (MSM/Heterosexual)Estimates estimated HIV transmission risk per exposure type to counsel patients and guide PrEP/PEP decisions.
- Clinical Pulmonary Infection Score (CPIS)Diagnoses ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP). Score >6 suggests VAP.
- Fever in Neutropenia Risk (MASCC)Multinational Association for Supportive Care in Cancer (MASCC) index for febrile neutropenia. Score ≥21 = low risk.
- IE Prophylaxis IndicationIdentifies patients requiring antibiotic prophylaxis before dental procedures based on ESC/AHA guidelines.
- WHO Severe Malaria CriteriaWHO 2015 criteria for severe P. falciparum malaria requiring parenteral artesunate and ITU-level care.
- FeverPAIN Score for Strep ThroatUK-derived 5-item clinical score to predict Group A Strep pharyngitis and guide antibiotic prescribing. Validated in UK primary care. Endorsed by NICE NG84.
- Kocher Criteria for Septic ArthritisPredicts probability of septic arthritis vs transient synovitis in children with acute hip pain. Validated by Caird et al. with CRP enhancement.
- Mantoux Test / TST Interpretation (TB)Tuberculin Skin Test (Mantoux) interpretation for latent TB infection (LTBI) screening. Induration threshold varies by risk group per NICE / WHO.
- HIV Incidence Risk Index for MSM (HIRI-MSM)Validated risk score identifying HIV-negative men who have sex with men (MSM) at highest risk for HIV acquisition who would benefit most from pre-exposure prophylaxis (PrEP). Derived from the EXPLORE cohort. Score 0–45; score ≥11 indicates high risk warranting PrEP discussion.
- HIV Needle-Stick Risk Assessment Stratification Protocol (RASP)Structured risk stratification tool guiding post-exposure prophylaxis (PEP) decisions following occupational or non-occupational HIV exposure. Considers source HIV status, exposure type, and clinical context to determine PEP indication.
- HIV CD4/Viral Load Monitoring IntervalsEvidence-based guide to CD4 count and viral load monitoring frequency in people living with HIV (PLHIV) on antiretroviral therapy (ART). Based on BHIVA HIV monitoring guidelines 2023. Helps determine appropriate review intervals.
- SOFA Score (Sepsis-3)Sequential Organ Failure Assessment (SOFA) score for organ dysfunction in ICU. Core of Sepsis-3 definition: sepsis = SOFA increase >=2.
- HIV CD4 Opportunistic Infection RiskStratifies risk of AIDS-defining opportunistic infections based on CD4 count. Guides prophylaxis decisions and clinical monitoring.
- Dengue Severity Classification (WHO 2009)Classifies dengue fever severity using WHO 2009 criteria. Guides fluid management, monitoring, and hospital admission decisions.
- Lower Respiratory Tract Infection (LRTI) Severity ScoreRapid severity assessment for lower respiratory tract infections to guide antibiotic prescribing and admission decisions in community settings.
- Influenza Severity Score (FluSS)Identifies high-risk influenza patients requiring antiviral therapy (oseltamivir) and hospital-level care.
- Hepatitis B Treatment Indication ScoreGuides antiviral therapy decision in chronic hepatitis B based on HBeAg status, viral load, ALT, and fibrosis stage.
- TB Treatment Adherence Risk (DOTS Assessment)Identifies patients at risk of TB treatment non-adherence to guide directly observed therapy (DOTS) allocation and social support.
- Malaria Severity Assessment (WHO Criteria)Classifies malaria as uncomplicated vs severe per WHO 2015 criteria. Severe malaria (Plasmodium falciparum) requires IV artesunate, not oral therapy.
- Duke Criteria for Infective EndocarditisDiagnoses infective endocarditis using major and minor Duke criteria. Guides echocardiography, blood culture interpretation, and empirical antibiotic selection.
- HIV Opportunistic Infection Risk (CD4-Based)Predicts risk of specific opportunistic infections by CD4 count threshold. Guides prophylaxis and diagnostic priorities in HIV-positive patients.
- Fever in Returning Traveller AssessmentStratifies risk and guides urgent investigation in febrile returning travellers. Malaria must be excluded in all cases.
- Clostridioides difficile Severity GradingGrades C. difficile infection (CDI) severity using ESCMID/IDSA criteria. Guides fidaxomicin vs vancomycin vs bezlotoxumab vs surgery decisions.
- MASCC Score (Febrile Neutropenia Risk)Predicts risk of serious complications in febrile neutropenia. MASCC score >=21 identifies low-risk patients eligible for outpatient oral antibiotic management.
- Toxoplasmosis Risk Assessment (Congenital and Immunocompromised)Assesses risk of active or congenital toxoplasmosis. Guides spiramycin/pyrimethamine-sulphadiazine therapy and neonatal screening.